Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
CNY 14.19
(-1.46%)
CNY 14.19
(-1.46%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 102.6 Million CNY | -49.45% |
| 2022 | 127.57 Million CNY | 2.3% |
| 2021 | 124.7 Million CNY | 5.94% |
| 2020 | 117.71 Million CNY | 6.32% |
| 2019 | 110.71 Million CNY | 3.41% |
| 2018 | 107.06 Million CNY | 21.89% |
| 2017 | 87.83 Million CNY | 336.51% |
| 2016 | 20.12 Million CNY | -56.75% |
| 2015 | 46.52 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 18.54 Million CNY | 61.6% |
| 2024 Q3 | 18.11 Million CNY | 59.85% |
| 2024 Q1 | 11.47 Million CNY | -26.69% |
| 2023 Q3 | 33.78 Million CNY | 55.0% |
| 2023 FY | 64.48 Million CNY | -49.45% |
| 2023 Q4 | 15.65 Million CNY | -53.66% |
| 2023 Q1 | 23.58 Million CNY | -15.09% |
| 2023 Q2 | 21.79 Million CNY | -7.6% |
| 2022 Q2 | 24.78 Million CNY | -14.82% |
| 2022 Q4 | 27.78 Million CNY | -39.49% |
| 2022 Q3 | 45.91 Million CNY | 85.24% |
| 2022 Q1 | 29.09 Million CNY | -5.0% |
| 2022 FY | 127.57 Million CNY | 2.3% |
| 2021 FY | 124.7 Million CNY | 5.94% |
| 2021 Q4 | 30.62 Million CNY | -26.81% |
| 2021 Q2 | 26.29 Million CNY | 1.37% |
| 2021 Q3 | 41.84 Million CNY | 59.18% |
| 2021 Q1 | 25.93 Million CNY | -8.05% |
| 2020 Q2 | 28.91 Million CNY | 42.02% |
| 2020 FY | 117.71 Million CNY | 6.32% |
| 2020 Q3 | 40.23 Million CNY | 39.14% |
| 2020 Q1 | 20.35 Million CNY | -31.08% |
| 2020 Q4 | 28.2 Million CNY | -29.89% |
| 2019 Q2 | 32.89 Million CNY | 105.01% |
| 2019 FY | 110.71 Million CNY | 3.41% |
| 2019 Q4 | 29.53 Million CNY | -8.36% |
| 2019 Q3 | 32.23 Million CNY | -2.02% |
| 2019 Q1 | 16.04 Million CNY | 0.0% |
| 2018 Q1 | 24.24 Million CNY | 0.0% |
| 2018 Q2 | 24.24 Million CNY | 0.0% |
| 2018 FY | 107.06 Million CNY | 21.89% |
| 2017 FY | 87.83 Million CNY | 336.51% |
| 2016 FY | 20.12 Million CNY | -56.75% |
| 2015 FY | 46.52 Million CNY | 0.0% |